No matter in the experimental group or the control group, in the subgroup analysis, changes in IL-6, IL-10, ALC, NLR, PLR, LDH and ALB over time were not statistically significant between the squamous carcinoma and non-squamous carcinoma groups, or between the combination therapy and monotherapy groups. This evidence concerns the gene IL10 and squamous cell carcinoma.